Certara, Inc., was incorporated in Delaware on June 27, 2017. The company utilizes biosimilar software and technology to accelerate the delivery of medicines to patients to transform the discovery and development of traditional medicines. Biosimulation is a powerful technique for conducting virtual trials with virtual patients to better understand the role of drugs in different individuals. Biopharmaceutical companies use their proprietary biosimilar software throughout the drug development process to inform critical decisions, which not only saves a lot of time and money, but also improves the safety and effectiveness of drugs, improving the lives of millions of people every year. 

CERT

CERT Profile